Cite
HARVARD Citation
Yale, J. et al. (n.d.). Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease. Diabetes, obesity & metabolism. 16 (10), pp. 1016-1027. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yale, J. et al. (n.d.). Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease. Diabetes, obesity & metabolism. 16 (10), pp. 1016-1027. [Online].